Valuation: Repligen Corporation

Market Cap 1.07TCr 971.97Cr 899.01Cr 811.14Cr 1.53TCr 1,01100Cr 1.58TCr 11TCr 4.28TCr 54TCr 4.03TCr 3.94TCr 1,71500Cr P/E 2026 *
-561x
P/E 2027 * 116x
Enterprise Value 991.49Cr 898.48Cr 831.04Cr 749.81Cr 1.41TCr 93TCr 1.46TCr 9.98TCr 3.96TCr 50TCr 3.72TCr 3.64TCr 1,58500Cr EV / Sales 2026 *
11.7x
EV / Sales 2027 * 9.07x
Free-Float
94.98%
Yield 2026 *
-
Yield 2027 * -
1 day+0.76%
1 week-3.29%
Current month-5.17%
1 month-4.35%
3 months+0.18%
6 months+56.77%
Current year+2.40%
1 week 163.85
Extreme 163.85
181.02
1 month 163.85
Extreme 163.85
191.05
Current year 100.99
Extreme 100.99
198.87
1 year 100.99
Extreme 100.99
198.87
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
300.23
10 years 28.48
Extreme 28.475
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Director/Board Member 61 01/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
06/10/26 Free

Executive/Senior Manager

1,375 0.0024%
05/10/26 Sell

Chief Executive Officer

-13,939 0.0247%
02/10/26 Tax

Chief Executive Officer

-1,248 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
+0.76%-3.29%+11.44%+15.16% 1.07TCr
+1.18%-1.28%-16.05%+13.29% 19TCr
+1.85%+1.04%+6.99%+42.70% 13TCr
-0.88%-4.98%-17.08%+9.86% 12TCr
+1.36%-5.91%-43.00%+3.16% 9.25TCr
+2.96%+7.64%-1.76%+80.54% 6.85TCr
+1.08%+2.90%+12.95%-7.56% 5.94TCr
+0.89%+4.17%+0.39%+62.87% 5.55TCr
-0.68%+6.83%-1.64%+55.26% 4.96TCr
-1.28%-0.43% - - 3.47TCr
Average +0.44%+0.19%-5.31%+30.59% 8TCr
Weighted average by Cap. +0.46%-0.44%-9.65%+27.07%

Financials

2026 *2027 *
Net sales 85Cr 77Cr 71Cr 64Cr 120.97Cr 8TCr 125.23Cr 854.66Cr 338.89Cr 4.28TCr 318.54Cr 311.78Cr 14TCr 106.97Cr 97Cr 90Cr 81Cr 152.45Cr 10TCr 157.82Cr 1.08TCr 427.07Cr 5.39TCr 401.42Cr 392.9Cr 17TCr
Net income -1.91Cr -1.73Cr -1.6Cr -1.44Cr -2.72Cr -179.83Cr -2.81Cr -19Cr -7.61Cr -96Cr -7.16Cr -7.01Cr -304.93Cr 8.91Cr 8.08Cr 7.47Cr 6.74Cr 13Cr 840.51Cr 13Cr 90Cr 36Cr 448.98Cr 33Cr 33Cr 1.43TCr
Net Debt -81Cr -73Cr -68Cr -61Cr -115.57Cr -7.65TCr -119.64Cr -816.5Cr -323.76Cr -4.08TCr -304.31Cr -297.86Cr -13TCr -102.18Cr -93Cr -86Cr -77Cr -145.62Cr -9.63TCr -150.75Cr -1.03TCr -407.94Cr -5.15TCr -383.44Cr -375.3Cr -16TCr
Projected Income Statement - Annual - Repligen Corporation
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
13/26/13 $167.79 +0.76% 5,10,112
12/26/12 $166.52 -3.53% 8,02,979
11/26/11 $172.62 -0.78% 10,00,618
10/26/10 $173.98 -2.77% 6,78,645
09/26/09 $178.94 +3.14% 10,96,250
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Repligen Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
167.79USD
Average target price
203.21USD
Spread / Average Target
+21.11%
  1. Stock Market
  2. Stocks
  3. RGEN Stock